Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 25, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Lung Cancer

Interventions

DRUG

Sorafenib

Starting dose 200 mg PO (by mouth) Daily

PROCEDURE

Radiation Therapy

45 Gy total in 15 radiation treatments: 3 Gy per day, 5 days a week for 3 weeks

Trial Locations (1)

UT MD . Anderson Cancer Center, Houston